Saturday, December 6, 2025

BMW Kicks off iX2 EDRIVE20 Pre-orders in South Korea

BMW Korea announced on the 2nd that...

Touching Tribute in Hawaii: South Korea’s President Honors U.S. War Heroes

South Korean President Yoon Suk Yeol honored...

OpenAI Just Went Global — And It’s Targeting Governments Next

OpenAI launches the OpenAI for Countries program to expand its AI presence globally by partnering with governments and localizing technology.

Tag: Novo Nordisk

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.